Dec 22, 2021
December 22, 2021 Lucira’s tests are the only available at-home self-test kits that deliver PCR-quality accuracy and early detectability in a single-use test kit with results in 30 minutes Current surge of COVID-19 cases caused by the Omicron variant highlights...
Dec 14, 2021
Contactless health monitoring technology developer Xandar Kardian announced today that it closed a $10 million Series A financing round. Toronto-based Xandar Kardian’s Series A round was led by Phoenix Venture Partners, Portfolia Active Aging & Longevity...
Nov 9, 2021
BY CHARLOTTE SCHUBERT on November 3, 2021 at 9:29 am Absci cut the ribbon on its new headquarters in Vancouver, Wash., on Tuesday, barely three months after going public in an IPO that valued the biotech company at nearly $2 billion. The 200-employee company...
Sep 8, 2021
ReForm Biologics, the Woburn startup that earlier this summer tapped former Genzyme CFO and Massachusetts Biotechnology Council co-founder Jim Sherblom as executive chairman, has netted another big fish in Jeffrey Hackman. Hackman joins the company as CEO after nearly...
Sep 8, 2021
WOBURN, Mass. – September 8, 2021– ReForm Biologics, Inc., a company developing a new generation of innovative biologic medicines to improve patient access, safety, and convenience, today announced the appointment of Jeffrey S. Hackman as President and Chief Executive...